| GO ID | GO:0042803 |
| Ontology | MF |
| GO Term | protein homodimerization activity |
| Definition | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
E2F8 |
E2F transcription factor 8 |
79733 |
A0AVK6 |
chr11: 19,224,063-19,241,620 |
|
ACOT7 |
acyl-CoA thioesterase 7 |
11332 |
O00154 |
chr1: 6,264,269-6,394,391 |
|
SDCBP |
syndecan binding protein |
6386 |
O00560 |
chr8: 58,552,924-58,582,860 |
|
PDXK |
pyridoxal (pyridoxine, vitamin B6) kinase |
8566 |
O00764 |
chr21: 43,719,094-43,762,307 |
|
BHLHE40 |
basic helix-loop-helix family member e40 |
8553 |
O14503 |
chr3: 4,979,116-4,985,323 |
|
KCNK3 |
potassium channel, two pore domain subfamily K, member 3 |
3777 |
O14649 |
chr2: 26,692,690-26,733,420 |
|
ADAM10 |
ADAM metallopeptidase domain 10 |
102 |
O14672 |
chr15: 58,588,807-58,749,978 |
|
AXIN1 |
axin 1 |
8312 |
O15169 |
chr16: 287,440-352,673 |
|
GSTA4 |
glutathione S-transferase alpha 4 |
2941 |
O15217 |
chr6: 52,977,948-52,995,378 |
|
SLC22A1 |
solute carrier family 22 (organic cation transporter), member 1 |
6580 |
O15245 |
chr6: 160,121,789-160,158,718 |
|
GRM6 |
glutamate receptor, metabotropic 6 |
2916 |
O15303 |
chr5: 178,978,327-178,996,206 |
|
MID1 |
midline 1 |
4281 |
O15344 |
chrX: 10,445,310-10,833,654 |
|
TOX3 |
TOX high mobility group box family member 3 |
27324 |
O15405 |
chr16: 52,438,005-52,547,802 |
|
FOXP2 |
forkhead box P2 |
93986 |
O15409 |
chr7: 114,086,327-114,693,772 |
|
IRAK2 |
interleukin 1 receptor associated kinase 2 |
3656 |
O43187 |
chr3: 10,164,865-10,243,743 |
|
MAP3K13 |
mitogen-activated protein kinase kinase kinase 13 |
9175 |
O43283 |
chr3: 185,282,941-185,489,097 |
|
DAPK3 |
death-associated protein kinase 3 |
1613 |
O43293 |
chr19: 3,958,453-3,971,123 |
|
RIPK2 |
receptor interacting serine/threonine kinase 2 |
8767 |
O43353 |
chr8: 89,757,747-89,791,063 |
|
TBX1 |
T-box 1 |
6899 |
O43435 |
chr22: 19,756,703-19,783,593 |
|
ACTN4 |
actinin, alpha 4 |
81 |
O43707 |
chr19: 38,647,649-38,731,583 |
|
GSTZ1 |
glutathione S-transferase zeta 1 |
2954 |
O43708 |
chr14: 77,320,884-77,331,597 |
|
NUDT21 |
nudix hydrolase 21 |
11051 |
O43809 |
chr16: 56,429,133-56,452,199 |
|
BNIP3L |
BCL2/adenovirus E1B 19kDa interacting protein 3-like |
665 |
O60238 |
chr8: 26,382,898-26,505,636 |
|
RAB11FIP3 |
RAB11 family interacting protein 3 (class II) |
9727 |
O75154 |
chr16: 425,619-523,011 |
|
PDCD6 |
programmed cell death 6 |
10016 |
O75340 |
chr5: 271,621-353,856 |
|
VPS4B |
vacuolar protein sorting 4 homolog B (S. cerevisiae) |
9525 |
O75351 |
chr18: 63,389,190-63,422,483 |
|
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
2081 |
O75460 |
chr17: 64,039,142-64,130,819 |
|
BANF1 |
barrier to autointegration factor 1 |
8815 |
O75531 |
chr11: 66,002,079-66,004,149 |
|
PRKRA |
protein kinase, interferon-inducible double stranded RNA dependent activator |
8575 |
O75569 |
chr2: 178,431,414-178,451,512 |
|
LRP6 |
LDL receptor related protein 6 |
4040 |
O75581 |
chr12: 12,116,025-12,267,012 |
|
IDH1 |
isocitrate dehydrogenase 1 (NADP+) |
3417 |
O75874 |
chr2: 208,236,227-208,266,074 |
|
STC2 |
stanniocalcin 2 |
8614 |
O76061 |
chr5: 173,314,713-173,329,503 |
|
RNF8 |
ring finger protein 8, E3 ubiquitin protein ligase |
9025 |
O76064 |
chr6: 37,353,972-37,394,738 |
|
SLIT2 |
slit guidance ligand 2 |
9353 |
O94813 |
chr4: 20,253,260-20,620,561 |
|
TRIM37 |
tripartite motif containing 37 |
4591 |
O94972 |
chr17: 58,982,638-59,106,921 |
|
VAPB |
VAMP (vesicle-associated membrane protein)-associated protein B and C |
9217 |
O95292 |
chr20: 58,389,122-58,451,101 |
|
PEX11B |
peroxisomal biogenesis factor 11 beta |
8799 |
O96011 |
chr1: 145,911,350-145,918,837 |
|
GOT2 |
glutamic-oxaloacetic transaminase 2 |
2806 |
P00505 |
chr16: 58,707,131-58,734,357 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
|
CD4 |
CD4 molecule |
920 |
P01730 |
chr12: 6,786,858-6,820,808 |
|
CRYAB |
crystallin alpha B |
1410 |
P02511 |
chr11: 111,908,565-111,923,722 |
|
APOE |
apolipoprotein E |
348 |
P02649 |
chr19: 44,905,754-44,909,393 |
|
APOA2 |
apolipoprotein A-II |
336 |
P02652 |
chr1: 161,222,292-161,223,631 |
|
AMBP |
alpha-1-microglobulin/bikunin precursor |
259 |
P02760 |
chr9: 114,060,127-114,078,472 |
|
TFRC |
transferrin receptor |
7037 |
P02786 |
chr3: 196,027,183-196,082,189 |
|
ANG |
angiogenin, ribonuclease, RNase A family, 5 |
283 |
P03950 |
chr14: 20,684,177-20,698,971 |
|
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
3156 |
P04035 |
chr5: 75,336,329-75,362,104 |
|
ANXA1 |
annexin A1 |
301 |
P04083 |
chr9: 73,151,757-73,170,393 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
S100B |
S100 calcium binding protein B |
6285 |
P04271 |
chr21: 46,598,962-46,605,208 |
|
VWF |
von Willebrand factor |
7450 |
P04275 |
chr12: 5,948,874-6,124,770 |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
|
TYMS |
thymidylate synthetase |
7298 |
P04818 |
chr18: 657,604-673,578 |
|
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
|
S100A6 |
S100 calcium binding protein A6 |
6277 |
P06703 |
chr1: 153,534,599-153,536,244 |
|
NPM1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
4869 |
P06748 |
chr5: 171,387,116-171,411,137 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
ADRB2 |
adrenoceptor beta 2 |
154 |
P07550 |
chr5: 148,825,245-148,828,687 |
|
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
|
ANXA6 |
annexin A6 |
309 |
P08133 |
chr5: 151,100,712-151,157,882 |
|
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
440 |
P08243 |
chr7: 97,852,118-97,872,542 |
|
IL6R |
interleukin 6 receptor |
3570 |
P08887 |
chr1: 154,405,193-154,469,450 |
|
SNRPC |
small nuclear ribonucleoprotein polypeptide C |
6631 |
P09234 |
chr6: 34,757,406-34,773,794 |
|
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
3956 |
P09382 |
chr22: 37,675,608-37,679,806 |
|
QDPR |
quinoid dihydropteridine reductase |
5860 |
P09417 |
chr4: 17,460,261-17,512,234 |
|
GSTM1 |
glutathione S-transferase mu 1 |
2944 |
P09488 |
chr1: 109,687,814-109,709,039 |
|
INHBB |
inhibin beta B |
3625 |
P09529 |
chr2: 120,346,143-120,351,808 |
|
HMOX1 |
heme oxygenase 1 |
3162 |
P09601 |
chr22: 35,380,361-35,394,214 |
|
BCL2 |
B-cell CLL/lymphoma 2 |
596 |
P10415 |
chr18: 63,123,346-63,320,128 |
|
MGST1 |
microsomal glutathione S-transferase 1 |
4257 |
P10620 |
chr12: 16,347,142-16,609,259 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
GHR |
growth hormone receptor |
2690 |
P10912 |
chr5: 42,423,777-42,721,878 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
TOP2A |
topoisomerase (DNA) II alpha |
7153 |
P11388 |
chr17: 40,388,516-40,417,950 |
|
G6PD |
glucose-6-phosphate dehydrogenase |
2539 |
P11413 |
chrX: 154,531,391-154,547,572 |
|
PRPS2 |
phosphoribosyl pyrophosphate synthetase 2 |
5634 |
P11908 |
chrX: 12,791,355-12,824,222 |
|
ODC1 |
ornithine decarboxylase 1 |
4953 |
P11926 |
chr2: 10,439,968-10,448,504 |
|
TPR |
translocated promoter region, nuclear basket protein |
7175 |
P12270 |
chr1: 186,311,652-186,375,693 |
|
ACTN1 |
actinin, alpha 1 |
87 |
P12814 |
chr14: 68,874,143-68,979,440 |
|
CCL5 |
chemokine (C-C motif) ligand 5 |
6352 |
P13501 |
chr17: 35,871,491-35,880,793 |
|
ENO3 |
enolase 3 (beta, muscle) |
2027 |
P13929 |
chr17: 4,948,092-4,957,131 |
|
ADRB3 |
adrenoceptor beta 3 |
155 |
P13945 |
chr8: 37,962,991-37,966,965 |
|
DRD2 |
dopamine receptor D2 |
1813 |
P14416 |
chr11: 113,409,615-113,475,691 |
|
TYR |
tyrosinase |
7299 |
P14679 |
chr11: 89,177,452-89,295,759 |
|
IDE |
insulin-degrading enzyme |
3416 |
P14735 |
chr10: 92,451,684-92,574,076 |
|
JUP |
junction plakoglobin |
3728 |
P14923 |
chr17: 41,754,604-41,786,931 |
|
PVR |
poliovirus receptor |
5817 |
P15151 |
chr19: 44,643,798-44,663,583 |
|
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
3248 |
P15428 |
chr4: 174,490,177-174,523,154 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
TCF4 |
transcription factor 4 |
6925 |
P15884 |
chr18: 55,222,331-55,664,787 |
|
RAG1 |
recombination activating gene 1 |
5896 |
P15918 |
chr11: 36,510,709-36,593,156 |
|
TCF3 |
transcription factor 3 |
6929 |
P15923 |
chr19: 1,609,290-1,652,605 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
PRLR |
prolactin receptor |
5618 |
P16471 |
chr5: 35,048,756-35,230,589 |
|
NPR3 |
natriuretic peptide receptor 3 |
4883 |
P17342 |
chr5: 32,689,070-32,791,724 |
|
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
1051 |
P17676 |
chr20: 50,190,734-50,192,689 |
|
HLA-G |
major histocompatibility complex, class I, G |
3135 |
P17693 |
chr6: 29,826,967-29,831,125 |
|
RPL7 |
ribosomal protein L7 |
6129 |
P18124 |
chr8: 73,290,267-73,295,789 |
|
ATF3 |
activating transcription factor 3 |
467 |
P18847 |
chr1: 212,565,334-212,620,777 |
|
SRM |
spermidine synthase |
6723 |
P19623 |
chr1: 11,054,584-11,060,024 |
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
|
GSTM3 |
glutathione S-transferase mu 3 (brain) |
2947 |
P21266 |
chr1: 109,733,932-109,741,038 |
|
FLNA |
filamin A |
2316 |
P21333 |
chrX: 154,348,524-154,374,638 |
|
AGXT |
alanine-glyoxylate aminotransferase |
189 |
P21549 |
chr2: 240,868,479-240,880,502 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
2065 |
P21860 |
chr12: 56,079,857-56,103,505 |
|
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 |
P22413 |
chr6: 131,808,016-131,895,155 |
|
XPA |
xeroderma pigmentosum, complementation group A |
7507 |
P23025 |
chr9: 97,674,909-97,697,357 |
|
CBLN1 |
cerebellin 1 precursor |
869 |
P23435 |
chr16: 49,277,917-49,281,831 |
|
SP100 |
SP100 nuclear antigen |
6672 |
P23497 |
chr2: 230,415,942-230,544,090 |
|
NR2F2 |
nuclear receptor subfamily 2 group F member 2 |
7026 |
P24468 |
chr15: 96,325,938-96,340,263 |
|
TARS |
threonyl-tRNA synthetase |
6897 |
P26639 |
chr5: 33,440,696-33,469,539 |
|
STOM |
stomatin |
2040 |
P27105 |
chr9: 121,338,988-121,370,304 |
|
PON1 |
paraoxonase 1 |
5444 |
P27169 |
chr7: 95,297,676-95,324,707 |
|
MAOB |
monoamine oxidase B |
4129 |
P27338 |
chrX: 43,766,611-43,882,447 |
|
DPP4 |
dipeptidyl-peptidase 4 |
1803 |
P27487 |
chr2: 161,992,241-162,074,542 |
|
DCK |
deoxycytidine kinase |
1633 |
P27707 |
chr4: 70,992,538-71,030,914 |
|
GSTM2 |
glutathione S-transferase mu 2 (muscle) |
2946 |
P28161 |
chr1: 109,668,022-109,709,551 |
|
ABCD3 |
ATP binding cassette subfamily D member 3 |
5825 |
P28288 |
chr1: 94,418,455-94,518,666 |
|
MZF1 |
myeloid zinc finger 1 |
7593 |
P28698 |
chr19: 58,561,931-58,573,575 |
|
IMPA1 |
inositol(myo)-1(or 4)-monophosphatase 1 |
3612 |
P29218 |
chr8: 81,657,961-81,686,693 |
|
TKT |
transketolase |
7086 |
P29401 |
chr3: 53,224,707-53,256,052 |
|
ERP29 |
endoplasmic reticulum protein 29 |
10961 |
P30040 |
chr12: 112,013,316-112,023,451 |
|
CLIP1 |
CAP-Gly domain containing linker protein 1 |
6249 |
P30622 |
chr12: 122,271,432-122,422,632 |
|
CORO1A |
coronin, actin binding protein, 1A |
11151 |
P31146 |
chr16: 30,182,827-30,189,076 |
|
S100A11 |
S100 calcium binding protein A11 |
6282 |
P31949 |
chr1: 152,032,506-152,047,907 |
|
SHMT1 |
serine hydroxymethyltransferase 1 (soluble) |
6470 |
P34896 |
chr17: 18,327,860-18,363,563 |
|
RDX |
radixin |
5962 |
P35241 |
chr11: 110,174,880-110,296,722 |
|
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 |
P35354 |
chr1: 186,671,791-186,680,427 |
|
CBS |
cystathionine-beta-synthase |
875 |
P35520 |
chr21: 43,053,191-43,076,943 |
|
MYH9 |
myosin, heavy chain 9, non-muscle |
4627 |
P35579 |
chr22: 36,281,281-36,388,018 |
|
ACTN2 |
actinin, alpha 2 |
88 |
P35609 |
chr1: 236,686,454-236,764,631 |
|
CHKA |
choline kinase alpha |
1119 |
P35790 |
chr11: 68,052,859-68,121,444 |
|
HMGCL |
3-hydroxymethyl-3-methylglutaryl-CoA lyase |
3155 |
P35914 |
chr1: 23,801,885-23,838,620 |
|
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
1139 |
P36544 |
chr15: 31,923,438-32,173,018 |
|
CPOX |
coproporphyrinogen oxidase |
1371 |
P36551 |
chr3: 98,521,132-98,593,723 |
|
BMPR1A |
bone morphogenetic protein receptor type IA |
657 |
P36894 |
chr10: 86,756,601-86,932,838 |
|
IL6ST |
interleukin 6 signal transducer |
3572 |
P40189 |
chr5: 55,935,095-55,994,993 |
|
ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
3397 |
P41134 |
chr20: 31,605,283-31,606,515 |
|
CD200 |
CD200 molecule |
4345 |
P41217 |
chr3: 112,332,347-112,362,812 |
|
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
4681 |
P41271 |
chr1: 19,640,554-19,658,456 |
|
ECE1 |
endothelin converting enzyme 1 |
1889 |
P42892 |
chr1: 21,217,247-21,345,504 |
|
MSH2 |
mutS homolog 2 |
4436 |
P43246 |
chr2: 47,402,969-47,562,311 |
|
NR4A2 |
nuclear receptor subfamily 4 group A member 2 |
4929 |
P43354 |
chr2: 156,324,432-156,342,348 |
|
NAMPT |
nicotinamide phosphoribosyltransferase |
10135 |
P43490 |
chr7: 106,248,285-106,286,326 |
|
CBX5 |
chromobox 5 |
23468 |
P45973 |
chr12: 54,230,940-54,280,133 |
|
ALDH1A3 |
aldehyde dehydrogenase 1 family member A3 |
220 |
P47895 |
chr15: 100,877,714-100,916,626 |
|
XDH |
xanthine dehydrogenase |
7498 |
P47989 |
chr2: 31,334,321-31,414,715 |
|
SLC11A1 |
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
6556 |
P49279 |
chr2: 218,382,029-218,396,894 |
|
FASN |
fatty acid synthase |
2194 |
P49327 |
chr17: 82,078,333-82,098,332 |
|
CENPF |
centromere protein F |
1063 |
P49454 |
chr1: 214,603,195-214,664,588 |
|
PCYT1A |
phosphate cytidylyltransferase 1, choline, alpha |
5130 |
P49585 |
chr3: 196,214,222-196,287,957 |
|
HARS2 |
histidyl-tRNA synthetase 2 |
23438 |
P49590 |
chr5: 140,691,426-140,699,291 |
|
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
1052 |
P49716 |
chr8: 47,736,909-47,739,086 |
|
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
|
VEGFB |
vascular endothelial growth factor B |
7423 |
P49765 |
chr11: 64,234,538-64,238,793 |
|
TSC2 |
tuberous sclerosis 2 |
7249 |
P49815 |
chr16: 2,047,465-2,088,720 |
|
ASCL1 |
achaete-scute family bHLH transcription factor 1 |
429 |
P50553 |
chr12: 102,957,686-102,960,516 |
|
FXR1 |
fragile X mental retardation, autosomal homolog 1 |
8087 |
P51114 |
chr3: 180,868,141-180,982,753 |
|
IRAK1 |
interleukin 1 receptor associated kinase 1 |
3654 |
P51617 |
chrX: 154,010,500-154,019,980 |
|
CAV2 |
caveolin 2 |
858 |
P51636 |
chr7: 116,287,380-116,508,541 |
|
HSD17B4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
3295 |
P51659 |
chr5: 119,452,443-119,637,199 |
|
PSMD7 |
proteasome 26S subunit, non-ATPase 7 |
5713 |
P51665 |
chr16: 74,296,775-74,306,288 |
|
CLCN3 |
chloride channel, voltage-sensitive 3 |
1182 |
P51790 |
chr4: 169,612,633-169,723,673 |
|
NR0B1 |
nuclear receptor subfamily 0 group B member 1 |
190 |
P51843 |
chrX: 30,304,206-30,309,598 |
|
GTF2A2 |
general transcription factor IIA 2 |
2958 |
P52657 |
chr15: 59,638,062-59,657,541 |
|
HRSP12 |
heat-responsive protein 12 |
10247 |
P52758 |
chr8: 98,102,344-98,117,241 |
|
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
1054 |
P53567 |
chr19: 33,373,330-33,382,686 |
|
MVD |
mevalonate diphosphate decarboxylase |
4597 |
P53602 |
chr16: 88,651,935-88,663,161 |
|
TERF1 |
telomeric repeat binding factor (NIMA-interacting) 1 |
7013 |
P54274 |
chr8: 73,008,864-73,048,122 |
|
GYS2 |
glycogen synthase 2 |
2998 |
P54840 |
chr12: 21,536,189-21,604,847 |
|
CDH13 |
cadherin 13 |
1012 |
P55290 |
chr16: 82,626,803-83,800,640 |
|
TPD52 |
tumor protein D52 |
7163 |
P55327 |
chr8: 80,034,745-80,231,232 |
|
OXCT1 |
3-oxoacid CoA-transferase 1 |
5019 |
P55809 |
chr5: 41,730,065-41,870,519 |
|
CTBP2 |
C-terminal binding protein 2 |
1488 |
P56545 |
chr10: 124,984,317-125,161,170 |
|
TIRAP |
toll-interleukin 1 receptor (TIR) domain containing adaptor protein |
114609 |
P58753 |
chr11: 126,283,065-126,298,845 |
|
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
5631 |
P60891 |
chrX: 107,628,424-107,651,026 |
|
S100A10 |
S100 calcium binding protein A10 |
6281 |
P60903 |
chr1: 151,982,915-151,994,390 |
|
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
|
RACK1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
10399 |
P63244 |
chr5: 181,236,909-181,248,096 |
|
PAFAH1B2 |
platelet activating factor acetylhydrolase 1b catalytic subunit 2 |
5049 |
P68402 |
chr11: 117,144,267-117,176,894 |
|
ABAT |
4-aminobutyrate aminotransferase |
18 |
P80404 |
chr16: 8,674,565-8,784,575 |
|
CBX1 |
chromobox 1 |
10951 |
P83916 |
chr17: 48,070,052-48,101,521 |
|
SMAD3 |
SMAD family member 3 |
4088 |
P84022 |
chr15: 67,063,763-67,195,195 |
|
NDP |
Norrie disease (pseudoglioma) |
4693 |
Q00604 |
chrX: 43,948,776-43,973,504 |
|
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
3157 |
Q01581 |
chr5: 43,289,395-43,313,512 |
|
PLOD1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
5351 |
Q02809 |
chr1: 11,934,205-11,975,538 |
|
GSTM4 |
glutathione S-transferase mu 4 |
2948 |
Q03013 |
chr1: 109,656,081-109,674,836 |
|
HHEX |
hematopoietically expressed homeobox |
3087 |
Q03014 |
chr10: 92,689,951-92,695,646 |
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
|
ACVR1 |
activin A receptor type I |
90 |
Q04771 |
chr2: 157,736,444-157,875,862 |
|
ZBTB16 |
zinc finger and BTB domain containing 16 |
7704 |
Q05516 |
chr11: 114,059,593-114,250,676 |
|
FMR1 |
fragile X mental retardation 1 |
2332 |
Q06787 |
chrX: 147,911,951-147,951,125 |
|
BAX |
BCL2-associated X protein |
581 |
Q07812 |
chr19: 48,954,815-48,961,798 |
|
MCL1 |
myeloid cell leukemia 1 |
4170 |
Q07820 |
chr1: 150,574,551-150,579,738 |
|
SMAGP |
small cell adhesion glycoprotein |
57228 |
Q0VAQ4 |
chr12: 51,244,558-51,270,890 |
|
BST2 |
bone marrow stromal cell antigen 2 |
684 |
Q10589 |
chr19: 17,402,939-17,405,648 |
|
KCNH2 |
potassium channel, voltage gated eag related subfamily H, member 2 |
3757 |
Q12809 |
chr7: 150,944,961-150,978,315 |
|
DPYD |
dihydropyrimidine dehydrogenase |
1806 |
Q12882 |
chr1: 97,077,743-97,921,049 |
|
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
664 |
Q12983 |
chr10: 131,966,455-131,982,013 |
|
STK4 |
serine/threonine kinase 4 |
6789 |
Q13043 |
chr20: 44,966,474-45,079,959 |
|
CALCOCO2 |
calcium binding and coiled-coil domain 2 |
10241 |
Q13137 |
chr17: 48,830,988-48,866,522 |
|
PRDX4 |
peroxiredoxin 4 |
10549 |
Q13162 |
chrX: 23,664,262-23,686,399 |
|
MAD2L1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
4085 |
Q13257 |
chr4: 120,055,608-120,067,074 |
|
SMAD4 |
SMAD family member 4 |
4089 |
Q13485 |
chr18: 51,028,394-51,085,045 |
|
SQSTM1 |
sequestosome 1 |
8878 |
Q13501 |
chr5: 179,806,398-179,838,078 |
|
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
817 |
Q13557 |
chr4: 113,451,032-113,761,927 |
|
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
5311 |
Q13563 |
chr4: 88,007,668-88,077,777 |
|
TDG |
thymine DNA glycosylase |
6996 |
Q13569 |
chr12: 103,965,804-103,988,874 |
|
SNX1 |
sorting nexin 1 |
6642 |
Q13596 |
chr15: 64,094,123-64,146,090 |
|
MTMR1 |
myotubularin related protein 1 |
8776 |
Q13613 |
chrX: 150,692,971-150,765,103 |
|
MTMR2 |
myotubularin related protein 2 |
8898 |
Q13614 |
chr11: 95,832,882-95,925,315 |
|
CUL3 |
cullin 3 |
8452 |
Q13618 |
chr2: 224,470,150-224,585,397 |
|
GALE |
UDP-galactose-4-epimerase |
2582 |
Q14376 |
chr1: 23,795,599-23,800,804 |
|
HES1 |
hes family bHLH transcription factor 1 |
3280 |
Q14469 |
chr3: 194,136,145-194,138,732 |
|
MEF2D |
myocyte enhancer factor 2D |
4209 |
Q14814 |
chr1: 156,463,727-156,500,828 |
|
EEA1 |
early endosome antigen 1 |
8411 |
Q15075 |
chr12: 92,770,637-92,929,331 |
|
NECTIN1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
5818 |
Q15223 |
chr11: 119,623,408-119,729,084 |
|
PPP2R4 |
protein phosphatase 2A regulatory subunit 4 |
5524 |
Q15257 |
chr9: 129,110,950-129,148,946 |
|
QPRT |
quinolinate phosphoribosyltransferase |
23475 |
Q15274 |
chr16: 29,679,008-29,698,699 |
|
RABEP1 |
rabaptin, RAB GTPase binding effector protein 1 |
9135 |
Q15276 |
chr17: 5,282,265-5,385,812 |
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
|
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
8431 |
Q15466 |
chr1: 26,911,489-26,913,966 |
|
TWIST1 |
twist family bHLH transcription factor 1 |
7291 |
Q15672 |
chr7: 19,020,991-19,117,672 |
|
ELAVL1 |
ELAV like RNA binding protein 1 |
1994 |
Q15717 |
chr19: 7,958,579-8,005,659 |
|
SMAD2 |
SMAD family member 2 |
4087 |
Q15796 |
chr18: 47,808,957-47,931,146 |
|
SMAD1 |
SMAD family member 1 |
4086 |
Q15797 |
chr4: 145,481,194-145,558,079 |
|
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
9370 |
Q15848 |
chr3: 186,842,690-186,858,463 |
|
USF2 |
upstream transcription factor 2, c-fos interacting |
7392 |
Q15853 |
chr19: 35,268,978-35,279,821 |
|
EXT1 |
exostosin glycosyltransferase 1 |
2131 |
Q16394 |
chr8: 117,794,490-118,111,853 |
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
4915 |
Q16620 |
chr9: 84,668,551-85,027,070 |
|
KYNU |
kynureninase |
8942 |
Q16719 |
chr2: 142,877,498-143,055,832 |
|
PTPRO |
protein tyrosine phosphatase, receptor type, O |
5800 |
Q16827 |
chr12: 15,322,397-15,597,399 |
|
AOC3 |
amine oxidase, copper containing 3 |
8639 |
Q16853 |
chr17: 42,851,184-42,858,130 |
|
TPD52L1 |
tumor protein D52-like 1 |
7164 |
Q16890 |
chr6: 125,119,049-125,264,407 |
|
LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
9208 |
Q32MZ4 |
chr2: 237,627,576-237,813,682 |
|
CCDC88A |
coiled-coil domain containing 88A |
55704 |
Q3V6T2 |
chr2: 55,287,842-55,419,921 |
|
NADK2 |
NAD kinase 2, mitochondrial |
133686 |
Q4G0N4 |
chr5: 36,192,592-36,242,279 |
|
ANO6 |
anoctamin 6 |
196527 |
Q4KMQ2 |
chr12: 45,215,987-45,440,404 |
|
MLK4 |
Mitogen-activated protein kinase kinase kinase MLK4 |
84451 |
Q5TCX8 |
chr1: 233,327,768-233,385,148 |
|
OLFML2A |
olfactomedin like 2A |
169611 |
Q68BL7 |
chr9: 124,777,158-124,814,885 |
|
TENM4 |
teneurin transmembrane protein 4 |
26011 |
Q6N022 |
chr11: 78,652,831-79,440,948 |
|
JMJD6 |
jumonji domain containing 6 |
23210 |
Q6NYC1 |
chr17: 76,712,832-76,726,799 |
|
SLC27A1 |
solute carrier family 27 (fatty acid transporter), member 1 |
376497 |
Q6PCB7 |
chr19: 17,468,769-17,506,168 |
|
MTHFD1L |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
25902 |
Q6UB35 |
chr6: 150,865,549-151,101,887 |
|
OLFM4 |
olfactomedin 4 |
10562 |
Q6UX06 |
chr13: 53,028,759-53,052,057 |
|
RBPMS2 |
RNA binding protein with multiple splicing 2 |
348093 |
Q6ZRY4 |
chr15: 64,739,892-64,775,587 |
|
RAB11FIP2 |
RAB11 family interacting protein 2 (class I) |
22841 |
Q7L804 |
chr10: 118,004,916-118,046,603 |
|
EMSY |
EMSY, BRCA2-interacting transcriptional repressor |
56946 |
Q7Z589 |
chr11: 76,444,923-76,553,025 |
|
SLC51A |
solute carrier family 51 alpha subunit |
200931 |
Q86UW1 |
chr3: 196,211,487-196,243,178 |
|
SPATA24 |
spermatogenesis associated 24 |
202051 |
Q86W54 |
chr5: 139,396,563-139,404,088 |
|
CARM1 |
coactivator associated arginine methyltransferase 1 |
10498 |
Q86X55 |
chr19: 10,871,513-10,923,070 |
|
CEP57 |
centrosomal protein 57kDa |
9702 |
Q86XR8 |
chr11: 95,789,965-95,832,693 |
|
CCDC103 |
coiled-coil domain containing 103 |
388389 |
Q8IW40 |
chr17: 44,899,142-44,905,390 |
|
SLC30A8 |
solute carrier family 30 (zinc transporter), member 8 |
169026 |
Q8IWU4 |
chr8: 116,950,273-117,176,714 |
|
KLHL7 |
kelch like family member 7 |
55975 |
Q8IXQ5 |
chr7: 23,105,758-23,177,914 |
|
SUPV3L1 |
SUV3-like helicase |
6832 |
Q8IYB8 |
chr10: 69,180,232-69,209,099 |
|
NLGN4X |
neuroligin 4, X-linked |
57502 |
Q8N0W4 |
chrX: 5,840,637-6,228,863 |
|
ADSSL1 |
adenylosuccinate synthase like 1 |
122622 |
Q8N142 |
chr14: 104,724,186-104,747,325 |
|
CISD2 |
CDGSH iron sulfur domain 2 |
493856 |
Q8N5K1 |
chr4: 102,868,978-102,889,242 |
|
COMMD1 |
copper metabolism (Murr1) domain containing 1 |
150684 |
Q8N668 |
chr2: 61,888,724-62,147,247 |
|
FAM73A |
family with sequence similarity 73 member A |
374986 |
Q8NAN2 |
chr1: 77,779,624-77,879,539 |
|
ZBTB38 |
zinc finger and BTB domain containing 38 |
253461 |
Q8NAP3 |
chr3: 141,324,213-141,449,792 |
|
SUMF1 |
sulfatase modifying factor 1 |
285362 |
Q8NBK3 |
chr3: 3,700,814-4,467,281 |
|
UXS1 |
UDP-glucuronate decarboxylase 1 |
80146 |
Q8NBZ7 |
chr2: 106,093,303-106,194,339 |
|
LILRB1 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 |
Q8NHL6 |
chr19: 54,617,158-54,637,528 |
|
GABPB2 |
GA binding protein transcription factor, beta subunit 2 |
126626 |
Q8TAK5 |
chr1: 151,070,578-151,125,542 |
|
SPPL3 |
signal peptide peptidase like 3 |
121665 |
Q8TCT6 |
chr12: 120,762,510-120,904,371 |
|
SPPL2A |
signal peptide peptidase like 2A |
84888 |
Q8TCT8 |
chr15: 50,702,266-50,765,808 |
|
HM13 |
histocompatibility (minor) 13 |
81502 |
Q8TCT9 |
chr20: 31,514,428-31,577,923 |
|
SCARB1 |
scavenger receptor class B member 1 |
949 |
Q8WTV0 |
chr12: 124,776,856-124,882,668 |
|
PDCD6IP |
programmed cell death 6 interacting protein |
10015 |
Q8WUM4 |
chr3: 33,798,352-33,869,707 |
|
MITD1 |
microtubule interacting and trafficking domain containing 1 |
129531 |
Q8WV92 |
chr2: 99,161,427-99,181,058 |
|
NR4A3 |
nuclear receptor subfamily 4 group A member 3 |
8013 |
Q92570 |
chr9: 99,821,855-99,866,891 |
|
BCL2L2 |
BCL2L2-PABPN1 readthrough |
599 |
Q92843 |
chr14: 23,298,790-23,311,759 |
|
RBPMS |
RNA binding protein with multiple splicing |
11030 |
Q93062 |
chr8: 30,384,479-30,572,261 |
|
NUDT16 |
nudix hydrolase 16 |
131870 |
Q96DE0 |
chr3: 131,381,671-131,388,830 |
|
S100A16 |
S100 calcium binding protein A16 |
140576 |
Q96FQ6 |
chr1: 153,606,886-153,613,145 |
|
DGAT2 |
diacylglycerol O-acyltransferase 2 |
84649 |
Q96PD7 |
chr11: 75,759,512-75,801,535 |
|
ALS2 |
ALS2, alsin Rho guanine nucleotide exchange factor |
57679 |
Q96Q42 |
chr2: 201,700,554-201,781,189 |
|
KIF20B |
kinesin family member 20B |
9585 |
Q96Q89 |
chr10: 89,701,610-89,774,939 |
|
TCF12 |
transcription factor 12 |
6938 |
Q99081 |
chr15: 56,918,623-57,299,281 |
|
P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
5025 |
Q99571 |
chr12: 121,209,857-121,234,106 |
|
S100A13 |
S100 calcium binding protein A13 |
6284 |
Q99584 |
chr1: 153,618,787-153,631,360 |
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
4217 |
Q99683 |
chr6: 136,557,047-136,792,518 |
|
MGLL |
monoglyceride lipase |
11343 |
Q99685 |
chr3: 127,689,062-127,823,250 |
|
BARD1 |
BRCA1 associated RING domain 1 |
580 |
Q99728 |
chr2: 214,725,646-214,809,711 |
|
ARID3A |
AT-rich interaction domain 3A |
1820 |
Q99856 |
chr19: 925,781-975,934 |
|
CITED1 |
Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1 |
4435 |
Q99966 |
chrX: 72,301,638-72,307,187 |
|
TREX2 |
three prime repair exonuclease 2 |
11219 |
Q9BQ50 |
chrX: 153,444,720-153,470,587 |
|
SYT11 |
synaptotagmin 11 |
23208 |
Q9BT88 |
chr1: 155,859,509-155,885,199 |
|
PDCD10 |
programmed cell death 10 |
11235 |
Q9BUL8 |
chr3: 167,683,298-167,734,939 |
|
JAM3 |
junctional adhesion molecule 3 |
83700 |
Q9BX67 |
chr11: 134,068,925-134,152,001 |
|
CADM1 |
cell adhesion molecule 1 |
23705 |
Q9BY67 |
chr11: 115,169,218-115,504,957 |
|
TRIM8 |
tripartite motif containing 8 |
81603 |
Q9BZR9 |
chr10: 102,644,496-102,658,407 |
|
FOXP3 |
forkhead box P3 |
50943 |
Q9BZS1 |
chrX: 49,250,436-49,264,826 |
|
TRIM9 |
tripartite motif containing 9 |
114088 |
Q9C026 |
chr14: 50,975,262-51,096,061 |
|
MFF |
mitochondrial fission factor |
56947 |
Q9GZY8 |
chr2: 227,325,151-227,357,836 |
|
DNTTIP1 |
deoxynucleotidyltransferase, terminal, interacting protein 1 |
116092 |
Q9H147 |
chr20: 45,791,937-45,811,427 |
|
SDCBP2 |
syndecan binding protein 2 |
27111 |
Q9H190 |
chr20: 1,309,909-1,329,239 |
|
IKZF4 |
IKAROS family zinc finger 4 |
64375 |
Q9H2S9 |
chr12: 56,007,659-56,038,435 |
|
MUC13 |
mucin 13, cell surface associated |
56667 |
Q9H3R2 |
chr3: 124,905,442-124,953,819 |
|
CHMP4B |
charged multivesicular body protein 4B |
128866 |
Q9H444 |
chr20: 33,811,304-33,854,366 |
|
GLIPR2 |
GLI pathogenesis-related 2 |
152007 |
Q9H4G4 |
chr9: 36,136,536-36,163,913 |
|
GREM2 |
gremlin 2, DAN family BMP antagonist |
64388 |
Q9H772 |
chr1: 240,489,573-240,612,149 |
|
ECT2 |
epithelial cell transforming 2 |
1894 |
Q9H8V3 |
chr3: 172,750,682-172,821,474 |
|
GRPEL1 |
GrpE-like 1, mitochondrial (E. coli) |
80273 |
Q9HAV7 |
chr4: 7,058,906-7,068,197 |
|
CACYBP |
calcyclin binding protein |
27101 |
Q9HB71 |
chr1: 174,999,163-175,011,715 |
|
APOBEC3G |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
60489 |
Q9HC16 |
chr22: 39,077,005-39,087,743 |
|
GOPC |
golgi-associated PDZ and coiled-coil motif containing |
57120 |
Q9HD26 |
chr6: 117,560,269-117,602,542 |
|
PLCB1 |
phospholipase C beta 1 |
23236 |
Q9NQ66 |
chr20: 8,077,251-8,968,360 |
|
HEYL |
hes-related family bHLH transcription factor with YRPW motif-like |
26508 |
Q9NQ87 |
chr1: 39,624,153-39,639,945 |
|
ANO2 |
anoctamin 2, calcium activated chloride channel |
57101 |
Q9NQ90 |
chr12: 5,531,869-5,946,232 |
|
HPS4 |
Hermansky-Pudlak syndrome 4 |
89781 |
Q9NQG7 |
chr22: 26,443,423-26,483,837 |
|
NECTIN3 |
poliovirus receptor-related 3 |
25945 |
Q9NQS3 |
chr3: 111,070,071-111,275,563 |
|
PRDM6 |
PR domain containing 6 |
93166 |
Q9NQX0 |
chr5: 123,089,121-123,194,266 |
|
PDGFC |
platelet derived growth factor C |
56034 |
Q9NRA1 |
chr4: 156,760,454-156,971,394 |
|
PRTFDC1 |
phosphoribosyl transferase domain containing 1 |
56952 |
Q9NRG1 |
chr10: 24,848,607-24,952,604 |
|
ABCB10 |
ATP binding cassette subfamily B member 10 |
23456 |
Q9NRK6 |
chr1: 229,516,582-229,558,695 |
|
FGFR1OP2 |
FGFR1 oncogene partner 2 |
26127 |
Q9NVK5 |
chr12: 26,938,383-26,966,650 |
|
MTPAP |
mitochondrial poly(A) polymerase |
55149 |
Q9NVV4 |
chr10: 30,309,801-30,374,448 |
|
CLN6 |
ceroid-lipofuscinosis, neuronal 6, late infantile, variant |
54982 |
Q9NWW5 |
chr15: 68,206,992-68,257,211 |
|
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
23767 |
Q9NZU0 |
chr20: 14,322,988-14,337,616 |
|
ZBTB4 |
zinc finger and BTB domain containing 4 |
57659 |
Q9P1Z0 |
chr17: 7,459,366-7,484,263 |
|
TENM3 |
teneurin transmembrane protein 3 |
55714 |
Q9P273 |
chr4: 182,143,987-182,803,024 |
|
GRHPR |
glyoxylate reductase/hydroxypyruvate reductase |
9380 |
Q9UBQ7 |
chr9: 37,422,666-37,436,990 |
|
PLEKHB1 |
pleckstrin homology domain containing B1 |
58473 |
Q9UF11 |
chr11: 73,646,178-73,662,819 |
|
MLX |
MLX, MAX dimerization protein |
6945 |
Q9UH92 |
chr17: 42,567,068-42,573,239 |
|
GNPTG |
N-acetylglucosamine-1-phosphate transferase, gamma subunit |
84572 |
Q9UJJ9 |
chr16: 1,351,923-1,364,113 |
|
NUDT5 |
nudix hydrolase 5 |
11164 |
Q9UKK9 |
chr10: 12,165,325-12,196,144 |
|
ACSL6 |
Long-chain-fatty-acid--CoA ligase 6 |
23305 |
Q9UKU0 |
chr5: 131,949,973-132,012,243 |
|
BLOC1S6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
26258 |
Q9UL45 |
chr15: 45,587,123-45,615,999 |
|
FZD4 |
frizzled class receptor 4 |
8322 |
Q9ULV1 |
chr11: 86,945,679-86,955,391 |
|
PYCARD |
PYD and CARD domain containing |
29108 |
Q9ULZ3 |
chr16: 31,201,485-31,203,450 |
|
BOK |
BCL2-related ovarian killer |
666 |
Q9UMX3 |
chr2: 241,551,424-241,574,138 |
|
STUB1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
10273 |
Q9UNE7 |
chr16: 680,224-682,870 |
|
SNX6 |
sorting nexin 6 |
58533 |
Q9UNH7 |
chr14: 34,561,094-34,630,183 |
|
TIMELESS |
timeless circadian clock |
8914 |
Q9UNS1 |
chr12: 56,416,373-56,449,403 |
|
CRYL1 |
crystallin lambda 1 |
51084 |
Q9Y2S2 |
chr13: 20,403,667-20,525,857 |
|
SH3GLB1 |
SH3-domain GRB2-like endophilin B1 |
51100 |
Q9Y371 |
chr1: 86,704,570-86,748,184 |
|
SNX9 |
sorting nexin 9 |
51429 |
Q9Y5X1 |
chr6: 157,700,387-157,945,077 |
|
IRAK3 |
interleukin 1 receptor associated kinase 3 |
11213 |
Q9Y616 |
chr12: 66,188,879-66,254,622 |
|
CPQ |
carboxypeptidase Q |
10404 |
Q9Y646 |
chr8: 96,645,227-97,149,654 |